Protalix Biotherapeutics, Inc. (PLX)
2.29
-0.01
(-0.43%)
USD |
NYAM |
Apr 13, 16:00
2.295
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Cash from Investing (TTM) : -2.366M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Agenus, Inc. | 1.194M |
| Lisata Therapeutics, Inc. | 15.09M |
| InspireMD, Inc. | -30.56M |
| Lifeward Ltd. | -0.016M |
| Denali Therapeutics, Inc. | 255.28M |